1	Carcinoma, Non‐Small‐Cell Lung[MeSH Terms]
2	nsclc[Title/Abstract]
3	lung cancer*[Title/Abstract]
4	lung carcinoma[Title/Abstract]
5	lung neoplasm*[Title/Abstract]
6	lung tumor*[Title/Abstract]
7	lung tumour*[Title/Abstract]
8	non small cell*[Title/Abstract]
9	nonsmall cell*[Title/Abstract]
10	(#3 OR #4 OR #5 OR #6 OR #7) AND (#8 OR #9)
11	#1 OR #2 OR #10
12	anaplastic lymphoma kinase[Supplementary Concept]
13	alk[Title/Abstract]
14	anaplastic lymphoma kinase[Title/Abstract]
15	anaplastic lymphoma receptor tyrosine kinase[Title/Abstract]
16	CD246[Title/Abstract]
17	CD 246[Title/Abstract]
18	molecular targeted therapy[MeSH Terms]
19	target*[Title/Abstract]
20	crizotinib[Supplementary Concept]
21	crizotinib[Title/Abstract]
22	PF 02341066
23	PF02341066
24	xalkori[Title/Abstract]
25	ceritinib[Supplementary Concept]
26	ceritinib[Title/Abstract]
27	zykadia[Title/Abstract]
28	LDK378
29	CH5424802[Supplementary Concept]
30	alectinib[Title/Abstract]
31	RO5424802
32	entrectinib[Supplementary Concept]
33	entrectinib[Title/Abstract]
34	RXDX‐101
35	NMS‐E628
36	brigatinib[Title/Abstract]
37	AP26113
38	7‐amino‐12‐fluoro‐2,10,16‐trimethyl‐15‐oxo‐10,15,16,17‐tetrahydro‐2H‐8,4‐(metheno)pyrazolo(4,3‐h)(2,5,11)benzoxadiazacyclotetradecine‐3‐carbonitrile
39	lorlatinib[Title/Abstract]
40	PF06463922
41	PF‐06463922
42	ensartinib[Title/Abstract]
43	X396
44	receptor protein‐tyrosine kinases[MeSH Terms]
45	protein kinase inhibitors[MeSH Terms]
54	(((AP26113[Supplementary Concept]) OR AP26113) OR brigatinib[Title/Abstract]) OR Alunbrig[Title/Abstract]
58	((((entrectinib[Supplementary Concept]) OR entrectinib[Title/Abstract]) OR RXDX‐101) OR NMS‐E628) OR N‐(5‐(3,5‐difluorobenzyl)‐1H‐indazol‐3‐yl)‐4‐(4‐methyl‐1‐piperazinyl)‐2‐(tetrahydro‐2H‐pyran‐4‐ylamino)benzamide
60	#12 OR #13 OR #14 OR #15 OR #16 OR #17
61	#18 OR #19 OR #20 OR #21 OR #22 OR #23 OR #24 OR #25 OR #26 OR #27 OR #28 OR #29 OR #30 OR #31 OR #32 OR #33 OR #34 OR #35 OR #36 OR #37 OR #38 OR #39 OR #40 OR #41 OR #42 OR #43 OR #44 OR #45 OR #54 OR #58
62	#11 AND #60 AND #61
63	randomized controlled trial[Publication Type]
64	controlled clinical trial[Publication Type]
65	randomized[Title/Abstract]
66	placebo[Title/Abstract]
67	drug therapy[MeSH Subheading]
68	randomly[Title/Abstract]
69	trial[Title/Abstract]
70	groups[Title/Abstract]
71	#63 OR #64 OR #65 OR #66 OR #67 OR #68 OR #69 OR #70
72	animals [MeSH Terms] NOT humans [MeSH Terms]
73	#71 NOT #72
74	#62 AND #73